Spinal muscular atrophy-progressive myoclonic epilepsy syndrome
MONDO:0008045Spinal muscular atrophy-progressive myoclonic epilepsy syndrome is characterized by hereditary myoclonus and progressive distal muscular atrophy. Less than 10 cases have been reported. Treatment with clonazepam results in complete and lasting improvement of the myoclonus.
Also known as: Jankovic-Rivera syndrome, hereditary myoclonus-progressive distal muscular atrophy syndrome, Jankovic Rivera syndrome, SMAPME, hereditary myoclonus and progressive distal muscular atrophy, myoclonus hereditary progressive distal muscular atrophy, myoclonus, hereditary, with progressive distal muscular atrophy, spinal muscular atrophy with progressive myoclonic epilepsy
21 clinical trials for this condition and its sub-types, 0 tagged with Spinal muscular atrophy-progressive myoclonic epilepsy syndrome itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Brain study sheds light on Parkinson's and tics
Knowledge-focused CompletedThis completed study from the National Institute of Neurological Disorders and Stroke aimed to better understand how the brain controls movement and what goes wrong in movement disorders like Parkinson's disease, Tourette's syndrome, and dystonia. Over 1,200 adults—both patients …
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Wrist-Worn gadget could help doctors monitor Parkinson's at home
Knowledge-focused CompletedThis study tested a wrist-worn device called the Personal KinetiGraph (PKG) to see if it can accurately measure movement problems in people with Parkinson's disease. Nineteen participants wore the device while researchers compared its readings to standard clinical tests and video…
Sponsor: Global Kinetics Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC